<DOC>
	<DOCNO>NCT01449786</DOCNO>
	<brief_summary>More 70 % birch pollen allergic patient suffer allergic reaction certain food , e.g . stone fruit , hazelnut vegetable . However , specific immunotherapy ( SIT ) birch pollen extract effective treatment associate food allergy substantial number patient . Based previous clinical immunological investigation birch pollen relate food allergy ( BPRFA ) investigator hypothesize effective SIT abundant food allergy disease-eliciting food allergen employ . To prove concept , investigator aim sublingually administer major apple allergen , Mal 1 , birch pollen-allergic patient concomitant apple allergy evaluate clinical immunological effect treatment . The investigator choose Mal 1 model food allergen ( ) cross-reactivity Bet v 1 well characterize , ( ii ) apple frequent trigger BPRFA ( iii ) recombinant ( r ) Mal 1 well tolerate sublingual administration 20 birch pollen-allergic patient previous study . Sublingual administration define concentration GMP-rMal 1 compare equal dos GMP-rBet v 1 positive control placebo-treatment . Clinical parameter include skin prick test ( SPT ) objective subjective assessment apple birch pollen-induced allergic symptom . Immunological parameter comprise analysis antibody T cell response Mal 1 Bet v 1 well evaluation basophil activation . The propose pilot study first investigation concept specifically treat BPRFA involve food allergen thus , represent important step development efficient safe therapy future .</brief_summary>
	<brief_title>Sublingual Immunotherapy Birch Pollen Associated Apple Allergy</brief_title>
	<detailed_description />
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Rhinitis , Allergic , Seasonal</mesh_term>
	<criteria>otherwise healthy person 18 und 50 year age ; positive history rhinoconjunctivitis birch pollen oral allergy syndrome ( OAS ) apple positive skin prick test ( SPT ) reaction birch pollen apple specific IgE Bet v 1 Mal 1 Exclusion criterion Persons due physical mental state able provide inform consent . Persons underlie illness severe cardiopulmonary , malignant and/or autoimmune disease Persons suffer HyperIgE syndrome Persons receive SIT past 5 year person suffer severe allergic reaction apple generalize urticaria , asthma and/or anaphylaxis person suffer severe bronchial asthma birch pollen person suffer pathological alteration lips oral mucosa person prescribe treatment immunesuppressive drug , antihistamine , leukotrieneantagonists psychotropic drug antihistaminic effect person use ÃŸblockers Pregnant woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2011</verification_date>
</DOC>